about
miR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer.Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer.Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancerGenomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genesSerum LOX-1 is a novel prognostic biomarker of colorectal cancerEstablishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture
P50
Q46803210-EC914890-33C1-4899-AE4A-6FF74C777FE0Q50054318-A643C4C5-AADF-4FEF-BC39-16833F111CD2Q50422213-FA1B16CF-FC55-4BA7-B3C7-A56DE0F1C183Q55715408-B92EFA3A-C0C3-4E4B-A2D4-7E4CE40C0449Q64071897-39C074EF-6243-41B4-8180-C7FAAE85FD3CQ91779053-D8530A50-CF5B-4F25-BD51-AC7A35C19C14Q91818874-4A0E7F51-2AC6-4432-963A-06D7D7E5BABAQ93120435-36F49DF4-B515-4B45-B5EA-4066BC3C4ED9
P50
description
researcher
@en
name
Shoichi Hazama
@en
type
label
Shoichi Hazama
@en
prefLabel
Shoichi Hazama
@en
P31
P496
0000-0002-5239-8570